Operationalizing a proposed national protocol for the prevention and management of severe pre-eclampsia and eclampsia using a loading dose of magnesium sulphate at community health facilities in Bangladesh
About 20 percent of maternal deaths in Bangladesh are caused by pre-eclampsia and eclampsia. Most of these deaths, which occur during care within local communities due to lack of maternal health information, poor antenatal care attendance, and delays in seeking care, can be easily prevented with low-cost maternal health commodities. A quasi-experimental pre- and post-test study, with no control group, was implemented to assess the abilities of community facility service providers to screen and detect eclampsia patients, administer a loading dose of magnesium sulphate to diagnosed patients, and refer them to an appropriate facility for condition management. These interventions were instituted for nine months in 19 Union Health and Family Welfare Centers and 53 community clinics in two upazilas in Brahmanbaria district. The general objective of this study was to assess the abilities of community facility-based service providers in screening and detecting PE/E patients, then administering a loading dose of MgSO4 to appropriate patients and referring them to higher-level-care facilities. This report presents findings from this study.
"Operationalizing a proposed national protocol for the prevention and management of severe pre-eclampsia and eclampsia using a loading dose of magnesium sulphate at community health facilities in Bangladesh." Washington, DC: Population Council, 2014.
Use of Magnesium Sulfate to Treat Pre-Eclampsia and Eclampsia